Systemic lupus erythematosus (SLE), the embodiment of a multi-organ autoimmune disease, results from hyperactivation of host-defence pathways and immune recognition of the most fundamental building blocks of life. In 2018, key advances have placed intestinal immunity and dysregulated expansions of candidate pathobionts at the forefront of SLE pathogenesis.

The Microbiome and Systemic Lupus Erythematosus

Systemic Lupus Erythematosus and dysbiosis in the microbiome: cause or effect or both?

“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort

Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstoma

Precision Nutrition in Chronic Inflammation

Thermoneutrality and Immunity: How Does Cold Stress Affect Disease?

Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy

The Tellurium-based Immunomodulator, AS101 Ameliorates Adjuvant-Induced Arthritis in Rats in Clinical & Experimental Immunology

Infections are Associated With Increased Risk of Giant Cell Arteritis: A Population-based Case-control Study from Southern Sweden